CIBC Bancorp USA’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
52,355
-9,530
-15% -$302K ﹤0.01% 1005
2026
Q1
$1.95M Buy
+61,885
New +$1.95M ﹤0.01% 911

Other funds holding RTO

CIBC Bancorp USA's RTO Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Rentokil (RTO) stake by 15% in Q2 2026, selling an estimated $302K and leaving 52,355 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

CIBC Bancorp USA first reported a position in RTO in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.95M in Q1 2026. 274 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • CIBC Bancorp USA held 52,355 shares of Rentokil worth $1.5M as of Q2 2026.
  • CIBC Bancorp USA sold 9,530 Rentokil shares in Q2 2026, an estimated $302K.
  • Rentokil made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1005 holding.
  • CIBC Bancorp USA first reported a position in Rentokil in Q1 2026 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Rentokil position peaked at $1.95M in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.